ISRCTN ISRCTN41474586
DOI https://doi.org/10.1186/ISRCTN41474586
Secondary identifying numbers N/A
Submission date
11/10/2010
Registration date
24/11/2010
Last edited
30/03/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Mrs Irene Bachmann
Scientific

Institut für Hausarztmedizin
Universitätsspital
Sonneggstrasse 6
Zurich
8091
Switzerland

Email irene.bachmann@usz.ch

Study information

Study designMulticentre parallel-group randomised two-arm intervention trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleEffect of case management on the quality of life in patients with cancer after one year of ambulant rehabilitation - a randomised, controlled, parallel-group clinical trial
Study acronymCAMON
Study objectivesThe implementation of several elements of the Chronic Care Model (CCM) via a case manager in the rehabilitation (trained registered oncology nurse) has a positive effect of the quality of life of cancer patients one year after an adjuvant therapy.
Ethics approval(s)Ethics Board of the Kanton Zurich (Switzerland), 20/05/2010, ref: KEK-ZH-NR-2009 - 0145/1
Health condition(s) or problem(s) studiedCancer - neoplasm
InterventionApart from the usual medical provision, i.e., consultations with the general practitioner and oncologist, and the therapies and measures prescribed as part of rehabilitation - randomised patients in the intervention group will be allocated an additional contact person (case manager) for the duration of one year after completion of adjuvant therapy. The contact person will be concerned with non-medical issues, information brokerage, encouragement of self-management and self-efficacy, as well as individually planning the rehabilitation program, and giving support with coordination management. The task is carried out by an experienced oncology nurse with additional training.

Patients who have been randomised in the control group will receive the usual medical provision.
Intervention typeOther
Primary outcome measureQuality of life: Fact G, (FACIT), measured at month 0, 3, 6 and 12
Secondary outcome measures1. Ability to work: recorded by means of sick leave questionnaire
2. Self-efficacy: Questionnaire self-efficacy expectation
3. Health care utilisation (general practitioner/oncologist, specialists and hospitalisation), illustrated as number of contacts: Questionnaire
4. Unplanned consultations (general practitioner/oncologist, specialists and hospitalisation), illustrated as number of contacts that were unplanned: Questionnaire
5. Satisfaction with medical care: PACIC Questionnaire
Overall study start date01/06/2010
Completion date31/12/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants132
Key inclusion criteria1. Aged 18 years or greater, either sex
2. Completion of a therapy with chemo- and/or radiotherapy/surgery (longer term hormone and antibody therapy are excluded)
3. Therapy with curative intention or longer term estimated survival time
4. Increased distress score (score 2 - 7)
5. Intention to undertake ambulant rehabilitation
6. Rehabilitation need/prevailing strain
Key exclusion criteria1. Patients with metastasis and/or cancer at an advanced stage with palliative therapy
2. Patients with an estimated survival time of less than one year
3. Patients with insufficient knowledge of the German language to take part in counselling and evaluations
4. Patients with severe psychiatric diagnoses or apparent great distress requiring medical psychiatric treatment
5. Completion of therapy longer than one month ago
Date of first enrolment01/06/2010
Date of final enrolment31/12/2011

Locations

Countries of recruitment

  • Switzerland

Study participating centre

Institut für Hausarztmedizin
Zurich
8091
Switzerland

Sponsor information

Swiss Cancer League (Krebsliga Schweiz) (Switzerland)
Charity

Effingerstrasse 40
Bern
3001
Switzerland

Email irene.bachmann@usz.ch
Website http://www.krebsliga.ch/de/index.cfm
ROR logo "ROR" https://ror.org/01pd7my79

Funders

Funder type

Charity

Krebsliga Schweiz
Private sector organisation / Other non-profit organizations
Alternative name(s)
Lega Svizzera Contro il Cancro, Swiss Cancer League, Ligue Suisse Contre le Cancer
Location
Switzerland
Universität Zürich
Government organisation / Universities (academic only)
Alternative name(s)
University of Zurich, Switzerland, University of Zurich, UZH
Location
Switzerland
University Hospital Zurich (Universitätsspital Zürich) (Switzerland)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 28/04/2011 Yes No
Results article results 28/03/2017 Yes No

Editorial Notes

30/03/2017: Publication reference added.